Adicet Bio Posts September 2026 Investor Presentation (8-K)

What Happened
Adicet Bio, Inc. (ACET) filed a Form 8-K on September 8, 2026 disclosing under Item 7.01 (Regulation FD Disclosure) that it posted a new investor presentation to the “Presentations & Events” section of its investor website (https://investor.adicetbio.com). The presentation is furnished as Exhibit 99.1 to the filing; the 8-K also includes the Inline XBRL cover page (Exhibit 104). The report was signed by Chief Financial Officer Nick Harvey on September 8, 2026. No earnings, financial results, or executive changes were reported in this filing.

Key Details

• Filing date: September 8, 2026 (Form 8-K).
• Item: 7.01 — Regulation FD Disclosure; presentation furnished as Exhibit 99.1.
• Website: presentation posted at https://investor.adicetbio.com (Presentations & Events).
• Signature: Signed by Nick Harvey, Chief Financial Officer; Exhibit 104 (Inline XBRL) included.

Why It Matters
This filing makes the company’s latest investor presentation publicly available and satisfies Reg FD requirements to broadly disclose material information. Investors should review the posted presentation for updated business or strategic information; because the 8-K does not report financial results or personnel changes, any specific financial or operational implications must be drawn from the presentation itself.